Curbing Diversion of Prescription Opioids Nathaniel Katz, MD, MS Tufts University School of Medicine Analgesic Research Opioid Prescribing to Adolescents.

Slides:



Advertisements
Similar presentations
Our role in the U.S. pharmaceutical supply chain:
Advertisements

Trend in Prescription Drug Abuse In 2004, 19.1 million Americans were current illicit drug users (7.9% of the U.S. population) 1 In 2004, 19.1 million.
National Take Back Initiative III. On October 29 from 10 a.m. to 2 p.m. Local Law Enforcement & the Drug Enforcement Administration (DEA) will give.
MAPS Michigan Automated Prescription System. Exempt From Reporting Medications administered directly to patients. Dispensing of up to a 48 hour supply.
National Prescription Drug Threat Assessment 2009 National Drug Intelligence Center Drug Enforcement Administration.
PTCB Review 3 Calculations Federal Law 1. How many 30-mg tablets of codeine sulfate should be used in preparing the following Rx? Rx: Codeine sulfate15.
CQC registration for providers of Primary Dental Services Medicines Management Caroline Crouch NHS Dorset.
Preventing Prescription Drug Abuse: Laws and Legislation Hollie Hendrikson, MSc Policy Specialist, Health Program.
Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015.
Opioids for Chronic Pain: Course Overview William Morrone, D.O., M.S. Medical Director, Hospice of Michigan Assistant Director, Family Medicine Synergy.
RISK EVALUATION AND MITIGATION STRATEGIES FOR LONG-ACTING OPIOID ANALGESICS REMS Katherine E. Galluzzi, D.O., CMD, FACOFP dist. Chair – AOA Council on.
CDER/CSS ALSDAC September 9-10, 2003 Risk Management and the Controlled Substances Act: The FDA Perspective Deborah B. Leiderman, M.D., M.A. Director Controlled.
Prevalence and Patterns of Nonmedical Use of OxyContin ® and Other Pain Relievers Joe Gfroerer Office of Applied Studies Substance Abuse and Mental Health.
Department of Health Professions PRESCRIPTION MONITORING PROGRAM ADVISORY COMMITTEE MEETING JUNE 10, 2008.
PSK Annual Conference 2008 Palliative care medicine: A balanced approach to opioid availability and safe use in Kenya Presenter: Dr. Bilha Kiama-Murage.
Anesthetic and Life Support Drugs, and Drug Safety and Risk Management Advisory Committees, November 13, 2008 Outpatient Drug Utilization Trends for Oxycodone.
1 Drug Utilization for Immediate- and Modified Release Opioids in the U.S. Gianna C. Rigoni, Pharm.D., M.S. Epidemiologist Division of Surveillance, Research.
Using the Maine PMP to Improve Prescribing Practices for Potentially Addictive Prescription Medications Susan Payne, MPH, PhD Research Professor Institute.
P HARMACY L AWS Pure Food and Drug Act Enacted to stop sale of inaccurately labeled drugs All manufacturers required to put truthful info on labels.
Mayor Jacobs Prescription Drug Task Force Update Presentation to Board of County Commissioners September 23, 2014.
Prescription Drug Abuse Sharon Hertz, M.D. Medical Officer Division of Anesthetic, Critical Care and Addiction Drug Products Food and Drug Administration.
Development of a Road Map to Controlled Substance Diversion Prevention Rene Cronquist, RN, J.D. Director of Practice and Policy Minnesota Board of Nursing.
Pharmaceutical Drug Abuse Counterfeit Drugs. Current State of Affairs National drug prevalence studies indicate a sharp increase in prescription drug.
Abuse Liability of Hydromorphone Extended Release Capsules Silvia N. Calderon, Ph.D. Controlled Substance Staff Center for Drug Evaluation and Research.
309: Prescription Drug Abuse. The Pennsylvania Child Welfare Resource Center Learning Objectives Participants will be able to: –Associate the history.
Slide 1 Overview of the Drug Formulary Commission and Statutory Objectives Bureau of Health Care Safety and Quality Department of Public Health August.
FDA REMS Program REMS: Risk Evaluation & Management Strategy
Drug Diversion, Sources, and Extent: United States Case Study Aaron M. Gilson, MS, MSSW, PhD Research Program Manager/Senior Scientist Pain & Policy Studies.
Slide 1 Best Practices Working Group Chapter 244 Acts of 2012 Joint Policy Working Group Bureau of Health Care Safety and Quality Director Madeleine Biondolillo,
Richard Z Aramini, PharmD PGY-1 Pharmacy Practice Resident Bay Pines VA Healthcare Center.
Introducing the Medication Recording System Schedule Ed Castagna Mom & Pop’s Small Business Services.
Opioid Risk Management Programs Celia Jaffe Winchell, M.D. Acting Deputy Division Director Division of Anesthetic, Critical Care, and Addiction Drug Products.
March 2004 Prescription Drug Abuse in the United States.
© 2004 by Thomson Delmar Learning, a part of the Thomson Corporation. Fundamentals of Pharmacology for Veterinary Technicians Chapter 1 A Brief History.
1 Alcohol and Substance Abuse Council of Jefferson County, Inc. 167 Polk Street, Suite 320 Watertown, New York Voice: ; Fax: ;
An integrated approach to addressing opiate abuse in Maine Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009.
Methods to Evaluate and Improve National Policy: Focus on 2011 WHO Guidelines and PPSG Global Policy Evaluation Aaron M. Gilson, MS, MSSW, PhD Research.
H.R Prescription drug abuse prevention and treatment Act of 2011.
Buprenorphine Treatment for Opioid Dependence CESAR FAX U n i v e r s i t y o f M a r y l a n d, C o l l e g e P a r k A Weekly FAX from the Center for.
Ensuring Availability and Preventing Diversion International Pain Policy Fellowship August 7, 2012 David E. Joranson University of Wisconsin Pain & Policy.
Accutane FDA (Section Name - Saver’s Initials) 3/9/00 12:50 PM 1 Risk Management Options Russell Ellison, MD Chief Medical Officer Vice President, Medical.
RESTICTED DRUGS Risk Evaluation and Mitigation Strategies--REMS
October 28, F OOD AND DRUG ADMINISTRATION AMENDMENTS ACT OF 2007 (FDAAA) and Risk Evaluation and Mitigation Strategies (REMS) Presented to the Ninth.
Summary Report and Recommendations on Prescription Drugs: Misuse, Abuse and Dependency Presentation for the County Alcohol and Drug Program Administrators’
TNSAM Addiction Medicine. Data source: Tennessee Department of Health, Office of Health Statistics, Death Statistical System. Overdose deaths were defined.
Daniel Wermeling, Pharm.D. Professor, College of Pharmacy.
دکترارتین کمالی ثابتی ( متخصص پزشکی قانونی ومسمومیتها )
Testimony of Sidney Wolfe, M.D. Health Research Group of Public Citizen FDA Drug Safety and Risk Management and Anesthetic and Analgesic Drug Products.
Drug Enforcement Administration Greater Kansas City Chapter American Society for Pain Management Nursing October 24, 2015 Judy R. Williams Group Supervisor.
Denis G. Patterson, DO ECHO Project April 20, 2016 CDC Guidelines for Prescribing Opioids for Chronic Pain.
Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Pennsylvania's Prescription Drug Monitoring Program (PDMP) May 17, 2016.
1 Benefit Integrity Medicare Drug Integrity Contractor (BI MEDIC): Health Integrity, LLC Tasha Trusty, RN BI MEDIC, Nurse Investigator Manager.
Tom Burns, Special Agent
Assisting the pharmacist
Wireless Access SSID: cwag2017
Legal and Regulatory Issues in Pain Management
*Risk Evaluation and Mitigation Strategy
The Role of Dentists in Preventing Opioid Abuse
American Public Health Association Annual Meeting November 5, 2007
ROOM project Addressing the Opioid Epidemic in the U.P.
Complete a legally valid prescription.
Federal Regulations requirements for opioid prescription course
Barbara Allison-Bryan, MD
PRESCRIPTION MONITORING PROGRAMS
Prescription Drug Monitoring Program
Prescription Drug Monitoring Program
2019 Medicare Part D Rule Opioid-related Provisions
Prescription Drug Monitoring Program
Ch 18: Pharmacy.
Presentation transcript:

Curbing Diversion of Prescription Opioids Nathaniel Katz, MD, MS Tufts University School of Medicine Analgesic Research Opioid Prescribing to Adolescents in Dental Settings National Institute of Drug Abuse February 23, 2009

Outline 1.Define and characterize diversion 2.Present what is known about sources of diverted prescription opioids 3.Speculate about role of dentists 4.Describe potential solutions

1 Define and Characterize Diversion

Definition of Diversion “The transfer of a controlled substance from a lawful to an unlawful channel of distribution or use.” Section 309, Diversion Prevention and Control Uniform Controlled Substances Act National Conference of Commissioners on Uniform State Laws, 1994 “means manufacture, possession,delivery or use of a controlled substance by a person or in a manner not specifically authorized by law.” Section 3302.(12) of the New York State Public Health Law

Diversion Examples Diversion Sharing Selling, buying Stealing Prescription forgery Doctor shopping Illegal internet Rx Criminal prescribing Not Diversion Using your own legitimately prescribed medication to get high (~20% of NMU)

2 What is Known About Sources of Diverted Prescription Opioids

Source of Pain Relievers by Past Year Users Aged ≥12: 2006 Totals may not =100% because of rounding or because suppressed estimates not shown “Other” includes: “Wrote fake prescription,” “Stole from doctor’s office/clinic/hospital/pharmacy,” & “Some other way. 68% from docs

5 Most Common Sources of Misused Prescription Opioids: By Population *For free & bought; † Own prescription, 1 doctor, & >1 doctor ‡ Stolen, stole from friend/family, theft, & forged prescription Percentage

Sources of Diverted Dosage Units Distribution System Manufacturers Distributors Pharmacies Hospitals/Clinics Internet Practitioners Nursing Homes Hospices Patients Primary Diversion Theft from Manufacturers Theft from Distributors Theft from Pharmacies Theft from Hospitals/Clinics Illegal Internet Internat’l Smuggling Forgery Script Doc/Pill Mill Doctor Shopping Patient Sells/Gives 2007 Total Doses 3,251, ,558 2,633, ,000,000? ? Tens of millions? ? ? ? TOTAL 1,000,000,000?

Criminal Prescribing: 1 case “The board investigator presented evidence that Brown was the single leading prescriber of OxyContin in the entire state, with his prescriptions accounting for 288,859 of the 922,985 OxyContin tablets sold through pharmacies in 2004.” For a 30-month period, Brown was the state's second largest prescriber of OxyContin

Schedule II Opioid Rx Dispensed to Individuals Showing Questionable Activity* *Questionable activity = obtained Schedule II opioid prescriptions from ≥4 pharmacies & ≥4 physicians during the specified yr Fiscal yr Estimated percentage 63,000 scripts million doses

Quantifying Diversion: Research Agenda Clean up NSDUH data: –Break down “non-medical use” data –How many dosage units ingested –How many dosage units acquired through different sources* –Update drug picture cards Clean up DEA Form 106 Database Compile Internet diversion data Compile criminal prescribing data; validate algorithms for identifying criminal prescribing Compile doctor shopping data; validate algorithms for identifying inappropriate doctor shopping

3 Speculate About the Role of Dentists in Prescription Opioid Diversion

14 Top Specialties Prescribing Immediate-Release Opioids, 1998 vs (WITH Hydrocodone & Oxycodone Combination Products) MD Specialty% Prescriptions FAMILY PRACTICE14.6% DENTISTRY12.2% INTERNAL MEDICINE12.2% ORTHOPEDIC SURGERY10.2% OSTEOPATHIC MEDICINE7.8% EMERGENCY MEDICINE6.1% GENERAL SURGERY3.6% OBSTETRICS/GYNECOLOGY3.2% ALL OTHERS30.2% MD Specialty% Prescriptions DENTISTRY15.5% FAMILY PRACTICE13.0% ORTHOPEDIC SURGERY11.5% INTERNAL MEDICINE11.1% OSTEOPATHIC MEDICINE6.7% EMERGENCY MEDICINE5.5% GENERAL SURGERY4.2% OBSTETRICS/GYNECOLOGY3.5% ALL OTHERS28.9% Source: IMS Health, National Prescription Audit Plus TM, Year 1998 to 2002, Excluding Long-Term Care & Mail Order Channels, Data Extracted August Dentists likely prescribe about a billion doses per year of opioids, mostly immediate-release combination products

Speculations About Role of Dentists in Prescription Opioid Diversion Dentists prescribe large volumes of drugs most commonly abused by adolescents and others The extent to which opioids are prescribed in greater quantities than necessary is unknown but probably considerable Anecdotal evidence suggests that adolescents use opioids non-medically that they or family members obtain from dentists Dentists rarely screen for opioid abuse risk factors or doctor shopping, monitor pts, educate them on risks of controlled substances or med storage/disposal, etc. It is not clear how well dentists understand the basic pharmacotherapy of pain and the appropriate role of opioids

4 Potential Solutions

FDA, Opioids, and REMS FDAAA September 2007 RISK EVALUATION AND MITIGATION STRATEGIES (REMS) REQUIREMENTS Title IX, Subtitle A, Section 901 of the Food and Drug Administration Amendments Act of 2007 (FDAAA) amends the Federal Food, Drug, and Cosmetic Act (FDCA) to authorize FDA to require the submission of a REMS for an approved drug if FDA becomes aware of new safety information and determines that such a strategy is necessary to ensure that the benefits of the drug outweigh the risks (section 505-1(a)). This provision took effect on March 25, 2008.

Switch-Based Retail Solution Prescriber Patient Explains Med Guide REMS registry Patient training- enrollment Retail Pharmacy Prescription brought Enrollment verified Prescription filled Data Client FDA Web-based training Switch company(ies) Closed Distribution

Solutions ProblemGeneral ApproachDentists Poor pt selection, monitoring, treatment REMS-based mandatory training (Not education) Guidelines Mandatory training Research Poor monitoringUrine drug monitoring Sharing/sellingUniversal pt education/training Nat’l awareness campaign Lockboxes Training dental pts Lockboxes Nat’l awareness campaign ForgeryTamper-proof scripts Doctor shoppingPrescription monitoring TheftRational disposal